T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Trimble
TRMB
$13.4B
| $77.4M | 0.02% |
3,119,200
-2,322,904
| -43% | -$51.3M |
|
627
Autodesk
ADSK
$54.5B
| $77.2M | 0.02% |
1,324,723
+558,656
| +73% | +$29.1M |
|
|
SYT
628
DELISTED
Syngenta Ag
SYT
| $77.1M | 0.02% |
931,250
+90,393
| +11% | +$7.12M |
|
629
Autoliv
ALV
$8.89B
| $77M | 0.02% |
898,409
+138,387
| +18% | +$11M |
|
630
Liberty Latin America Class C
LILAK
$1.65B
| $77M | 0.02% |
2,375,173
+212,040
| +10% | +$6.74M |
|
631
TechnipFMC
FTI
$30.1B
| $76.9M | 0.02% |
3,778,634
+890,924
| +31% | +$16.8M |
|
632
Matthews International
MATW
$722M
| $76.4M | 0.02% |
1,484,270
+2,930
| +0.2% | +$143K |
|
|
AVP
633
DELISTED
Avon Products, Inc.
AVP
| $76.3M | 0.02% |
15,870,178
+36,700
| +0.2% | +$131K |
|
|
B
634
Barrick Mining
B
$67.3B
| $76.2M | 0.02% |
5,607,429
+1,360,399
| +32% | +$15.8M |
|
635
Progress Software
PRGS
$1.83B
| $75.6M | 0.02% |
3,135,318
+142,281
| +5% | +$3.49M |
|
636
Veeco
VECO
$3.28B
| $75.6M | 0.02% |
3,881,682
-713,797
| -16% | -$13.1M |
|
637
Ryanair
RYAAY
$30.7B
| $75.3M | 0.02% |
2,194,525
-1,260,788
| -36% | -$41.6M |
|
|
BFS
638
Saul Centers
BFS
$865M
| $75M | 0.02% |
1,415,150
+13,440
| +1% | +$675K |
|
|
ROIC
639
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $74.9M | 0.02% |
3,722,570
+352,400
| +10% | +$6.52M |
|
|
ISEE
640
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $74.7M | 0.02% |
1,768,227
+128,300
| +8% | +$6.54M |
|
|
SCHW
641
Charles Schwab
SCHW
$190B
| $74.6M | 0.02% |
2,663,453
+59,440
| +2% | +$1.57M |
|
642
Hexcel
HXL
$7.74B
| $74.5M | 0.02% |
1,704,670
-9,075
| -0.5% | -$381K |
|
643
Southern Copper
SCCO
$158B
| $74.3M | 0.02% |
2,925,941
-735,334
| -20% | -$17.2M |
|
|
TDAY
644
USA Today Co
TDAY
$1B
| $74.2M | 0.02% |
4,460,743
+93,590
| +2% | +$1.53M |
|
|
ONCE
645
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $74.1M | 0.02% |
2,512,607
+459,679
| +22% | +$14.5M |
|
646
Grupo Aval
AVAL
$6.41B
| $73.8M | 0.02% |
9,542,710
-440,947
| -4% | -$2.96M |
|
647
MakeMyTrip
MMYT
$5.71B
| $73.8M | 0.02% |
4,077,294
-13,200
| -0.3% | -$237K |
|
648
LCI Industries
LCII
$2.6B
| $73.5M | 0.02% |
1,139,760
-27,890
| -2% | -$1.64M |
|
649
Ironwood Pharmaceuticals
IRWD
$674M
| $73.4M | 0.02% |
8,006,021
+1,895,117
| +31% | +$15.6M |
|
|
SGI
650
Somnigroup International
SGI
$14B
| $73M | 0.02% |
4,805,988
+4,704,480
| +4,635% | +$69.7M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.